Shawnte Mitchell - 02 Feb 2026 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Signature
/s/ Shawnte Mitchell
Issuer symbol
OLMA
Transactions as of
02 Feb 2026
Net transactions value
$0
Form type
4
Filing time
04 Feb 2026, 21:30:06 UTC
Previous filing
03 Mar 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mitchell Shawnte CHIEF LEGAL OFFICER C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN ST, SAN FRANCISCO /s/ Shawnte Mitchell 04 Feb 2026 0001749432

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLMA Stock Option (Right to Buy) Award $0 +220,000 $0.000000 220,000 02 Feb 2026 Common Stock 220,000 $25.65 Direct F1
transaction OLMA Performance Stock Options (Right to Buy) Award $0 +56,250 $0.000000 56,250 02 Feb 2026 Common Stock 56,250 $25.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on February 2, 2027, and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.
F2 The performance-based stock options will be eligible to vest during two distinct performance periods, each beginning on February 2, 2026 and ending on December 31, 2029 and December 31, 2030, respectively, based on the Issuer's stock price trading at certain pre-determined price thresholds as measured by the average closing price per share of the Issuer's stock over a consecutive thirty (30) day trading period during each such performance period. Once a price threshold is achieved, the portion of the award related to such threshold will vest upon the date set forth in the certification by the Compensation Committee certifying that such price threshold was achieved, subject to the Reporting Person's continuous service as of the applicable certification date.